Cited by 40Gynecological conditions and treatmentsUterine Myomas and TreatmentsEndometriosis Research and Treatment

Advanced endoscopic techniques used in dysfunctional bleeding, fibroids and endometriosis, and the role of gonadotrophin-releasing hormone agonist treatment

Donnez, J., Nisolle, M., Clerckx, F., Casanas‐Roux, F., Saussoy, P., Gillerot, S.·1994·BJOG: An International Journal of Obstetrics & Gynaecology

Abstract

peer reviewed

Integrity signals

Registry

Crossref · 10.1111/j.1471-0528.1994.tb13677.x

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • GnRH agonists cannot titrate E2 levels.

    “GnRH agonists are effective at treating endometriosis symptoms, but they have numerous limitations, including a delayed therapeutic impact because of the flare-up effect, excessive suppression of E2 to less than 20 pg/mL (with related unfavorable side effects), inability to titrate E2 levels, and unpredictable reversibility of treatment when injectable depot forms of GnRH agonists are used [95,96,”
  • GnRH agonists have unpredictable reversibility of treatment when injectable depot forms are used.

    “GnRH agonists are effective at treating endometriosis symptoms, but they have numerous limitations, including a delayed therapeutic impact because of the flare-up effect, excessive suppression of E2 to less than 20 pg/mL (with related unfavorable side effects), inability to titrate E2 levels, and unpredictable reversibility of treatment when injectable depot forms of GnRH agonists are used [95,96,”
  • GnRH agonists excessively suppress E2 to less than 20 pg/mL, with related unfavorable side effects.

    “GnRH agonists are effective at treating endometriosis symptoms, but they have numerous limitations, including a delayed therapeutic impact because of the flare-up effect, excessive suppression of E2 to less than 20 pg/mL (with related unfavorable side effects), inability to titrate E2 levels, and unpredictable reversibility of treatment when injectable depot forms of GnRH agonists are used [95,96,”
  • GnRH agonists have a delayed therapeutic impact because of the flare-up effect.

    “GnRH agonists are effective at treating endometriosis symptoms, but they have numerous limitations, including a delayed therapeutic impact because of the flare-up effect, excessive suppression of E2 to less than 20 pg/mL (with related unfavorable side effects), inability to titrate E2 levels, and unpredictable reversibility of treatment when injectable depot forms of GnRH agonists are used [95,96,”
  • GnRH agonists are effective at treating endometriosis symptoms.

    “GnRH agonists are effective at treating endometriosis symptoms, but they have numerous limitations, including a delayed therapeutic impact because of the flare-up effect, excessive suppression of E2 to less than 20 pg/mL (with related unfavorable side effects), inability to titrate E2 levels, and unpredictable reversibility of treatment when injectable depot forms of GnRH agonists are used [95,96,”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Donnez, J., Nisolle, M., Clerckx, F., Casanas‐Roux, F., Saussoy, P., & Gillerot, S.
Affiliations
Cliniques Universitaires Saint-Luc (BE)
Corresponding author
Donnez, J.
Venue
BJOG: An International Journal of Obstetrics & Gynaecology
Publisher
Wiley
Published
1994-05
Volume
101
Issue
s10
Pages
2-9
ISSN
  • 0306-5456 (ISSN-L)
  • 1470-0328
  • 1471-0528
OpenAlex
W2014564190
Cited by
40
References
32
Citations by year
2025: 1 · 2023: 1 · 2022: 2 · 2021: 2 · 2020: 1 · 2017: 1 · 2015: 1
FWCI
4.19
Type
journal article
Language
en
Open access
closed
Locations
  • BJOG An International Journal of Obstetrics & Gynaecology (publishedVersion)
  • PubMed (publishedVersion)
  • Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) (submittedVersion)
  • Open Repository and Bibliography (University of Liège) (submittedVersion)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
  • Health Sciences › Medicine › Obstetrics and Gynecology › Uterine Myomas and Treatments
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
Keywords
endoscopic technique, dysfunctional uterine bleeding, uterine fibroids, endometriosis, GnRH agonist, endometrial ablation, hysteroscopy
MeSH terms
Danazol, Endometriosis, Endometrium, Female, Follow-Up Studies, Humans, Leiomyoma, Menorrhagia, Preoperative Care, Uterine Neoplasms, Hysteroscopy, Hemostasis, Endoscopic, Treatment Outcome, Goserelin, Laser Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review